Innovating Works

E.F.A.

Desconocido
ImmUniverse: Better control and treatment of immune mediated diseases by exploring the universe of microenvironme... EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage Immune-mediated diseases (IMIDs) are an increasing medical burden in industrialized countries worldwide. IMIDs are characterized by an enorm...
2019-12-17 - 2024-12-31 | Financiado
3TR: Identification of the Molecular Mechanisms of non response to Treatments Relapses and Remission in... EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage 3TR is a transdisciplinary consortium made of experts in all areas of medicine, basic sciences and bioinformatics from academic institutions...
2019-08-22 - 2026-08-31 | Financiado
CURE: Constructing a Eubiosis Reinstatement Therapy for Asthma EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING participó en un H2020: H2020-FETOPEN-2016-2017 The asthma pandemic imposes a huge burden on patients and health systems in both developed and developing countries. Notwithstanding major e...
2017-08-29 - 2022-03-31 | Financiado
myAirCoach: Analysis modelling and sensing of both physiological and environmental factors for the customized a... EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING participó en un H2020: H2020-PHC-2014-2015 "myAirCoach aims to develop a holistic mHealth personalised asthma monitoring system empowering patients to manage their own health by provi...
2014-12-05 - 2018-06-30 | Financiado
AirPROM: Airway Disease PRedicting Outcomes through Patient Specific Computational Modelling EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING participó en un FP7: The airways diseases asthma and chronic obstructive pulmonary disease affect over 400 million people world-wide and cause considerable morbi...
Financiado
U-BIOPRED: Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING participó en un FP7: Rationale The inability of pre-clinical studies to predict clinical efficacy is a major bottleneck in drug development. In severe asthma thi...
Financiado
MEDALL: Mechanisms of the Development of ALLergy EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING participó en un FP7: Causes explaining the epidemic of IgE-associated (allergic) diseases are unclear. MeDALL (Mechanisms of the Development of Allergy) aims at...
Financiado
EARIP: European Asthma Research and Innovation Partnership EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING participó en un FP7: Europe has 30 million people with asthma, whose treatment costs about €20 bn annually. Productivity lost through poor asthma control in Euro...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.